Sheng Yan

2.1k total citations · 1 hit paper
49 papers, 1.6k citations indexed

About

Sheng Yan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sheng Yan has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Immunology and 9 papers in Oncology. Recurrent topics in Sheng Yan's work include T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Sheng Yan is often cited by papers focused on T-cell and B-cell Immunology (7 papers), Immunotherapy and Immune Responses (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Sheng Yan collaborates with scholars based in China, Hong Kong and United States. Sheng Yan's co-authors include Matthias Hoffmann, Oliver Pabst, Reinhold Förster, Tim Worbs, Günter Bernhardt, Gabriele Hintzen, Ulrike Bode, Geoffrey T. Swanson, Chak Sing Lau and Vera Chan and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Neuroscience.

In The Last Decade

Sheng Yan

46 papers receiving 1.6k citations

Hit Papers

Oral tolerance originates in the intestinal immune system... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Yan China 19 763 592 224 214 171 49 1.6k
Óscar M. Pello Spain 21 893 1.2× 815 1.4× 342 1.5× 211 1.0× 214 1.3× 31 1.9k
Je‐Min Choi South Korea 26 984 1.3× 913 1.5× 314 1.4× 163 0.8× 136 0.8× 68 2.1k
Zhongde Ye United States 21 575 0.8× 761 1.3× 259 1.2× 90 0.4× 157 0.9× 26 1.6k
Avijit Ray United States 20 896 1.2× 404 0.7× 169 0.8× 108 0.5× 174 1.0× 29 1.6k
Abdallah Badou Morocco 20 747 1.0× 537 0.9× 340 1.5× 81 0.4× 218 1.3× 61 1.7k
Maureen N. Ajuebor United States 23 945 1.2× 370 0.6× 362 1.6× 126 0.6× 284 1.7× 31 1.9k
Verena Raker Germany 16 629 0.8× 617 1.0× 158 0.7× 112 0.5× 149 0.9× 35 1.6k
Claudia Wahl Germany 14 953 1.2× 555 0.9× 210 0.9× 147 0.7× 196 1.1× 22 1.7k
Matteo Piazza Italy 16 355 0.5× 501 0.8× 164 0.7× 164 0.8× 113 0.7× 22 1.1k

Countries citing papers authored by Sheng Yan

Since Specialization
Citations

This map shows the geographic impact of Sheng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Yan more than expected).

Fields of papers citing papers by Sheng Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Yan. The network helps show where Sheng Yan may publish in the future.

Co-authorship network of co-authors of Sheng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Yan. A scholar is included among the top collaborators of Sheng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Yan. Sheng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Chengyu, Linyu Zhu, Gang Cheng, et al.. (2025). PD‐L1‐Targeting Biomimetic Photoresponsive Thermosensitive Liposomes for Triple‐Negative Breast Cancer. Advanced Science. 12(41). e06841–e06841. 1 indexed citations
2.
Lam, Sze Kwan, et al.. (2024). The anti-neoplastic impact of thymoquinone from Nigella sativa on small cell lung cancer: In vitro and in vivo investigations. Journal of Cancer Research and Therapeutics. 20(4). 1224–1231. 2 indexed citations
3.
Yan, Sheng, et al.. (2024). 14-3-3ε augments OGT stability by binding with S20-phosphorylated OGT. Journal of Biological Chemistry. 300(10). 107774–107774. 2 indexed citations
5.
Lam, Sze Kwan, Sheng Yan, Shi Xu, & Jcm Ho. (2020). Targeting polyamine as a novel therapy in xenograft models of malignant pleural mesothelioma. Lung Cancer. 148. 138–148. 4 indexed citations
6.
Ding, Yuan, et al.. (2019). Lymphoepithelioma-like intrahepatic cholangiocarcinoma with Epstein-Barr virus infection: report of a rare case. Annals of Translational Medicine. 7(18). 497–497. 17 indexed citations
7.
Dong, Xiaogang, et al.. (2018). Natural product pectolinarigenin inhibits proliferation, induces apoptosis, and causes G2/M phase arrest of HCC via PI3K/AKT/mTOR/ERK signaling pathway. OncoTargets and Therapy. Volume 11. 8633–8642. 29 indexed citations
8.
Liu, Leiming, Lingling Zhang, Lin Zhang, et al.. (2017). Hepatic Tmem30a Deficiency Causes Intrahepatic Cholestasis by Impairing Expression and Localization of Bile Salt Transporters. American Journal Of Pathology. 187(12). 2775–2787. 20 indexed citations
9.
Li, Michelle, et al.. (2017). Human CLEC16A regulates autophagy through modulating mTOR activity. Experimental Cell Research. 352(2). 304–312. 26 indexed citations
10.
Yan, Sheng, et al.. (2016). Peliosis hepatis: a report of one case. Zhonghua gan-dan waike zazhi. 22(2). 77–77.
11.
Ding, Yuan, Sheng Yan, Qiyi Zhang, et al.. (2014). Prediction of liver transplantation prognosis by transient elastography. 35(6). 346–349. 1 indexed citations
12.
Shen, Xiaoyong, Di Lu, Xiao Xu, et al.. (2013). A novel distinguishing system for the diagnosis of malignant pancreatic cystic neoplasm. European Journal of Radiology. 82(11). e648–e654. 3 indexed citations
13.
Graham, Sarah A., Sabine A.F. Jégouzo, Sheng Yan, et al.. (2009). Prolectin, a Glycan-binding Receptor on Dividing B Cells in Germinal Centers. Journal of Biological Chemistry. 284(27). 18537–18544. 20 indexed citations
14.
Deng, Junfang, Yigang Qian, Lei Geng, et al.. (2008). Involvement of p38 mitogen‐activated protein kinase pathway in honokiol‐induced apoptosis in a human hepatoma cell line (hepG2). Liver International. 28(10). 1458–1464. 43 indexed citations
16.
Worbs, Tim, Ulrike Bode, Sheng Yan, et al.. (2006). Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. The Journal of Experimental Medicine. 203(3). 519–527. 543 indexed citations breakdown →
17.
Vivithanaporn, Pornpun, Sheng Yan, & Geoffrey T. Swanson. (2006). Intracellular Trafficking of KA2 Kainate Receptors Mediated by Interactions with Coatomer Protein Complex I (COPI) and 14-3-3 Chaperone Systems. Journal of Biological Chemistry. 281(22). 15475–15484. 42 indexed citations
18.
Yan, Sheng, James M. Sanders, Jian Xu, et al.. (2004). A C-Terminal Determinant of GluR6 Kainate Receptor Trafficking. Journal of Neuroscience. 24(3). 679–691. 50 indexed citations
19.
Valluru, Lokanatha, Jian Xu, Yongling Zhu, et al.. (2004). Ligand Binding Is a Critical Requirement for Plasma Membrane Expression of Heteromeric Kainate Receptors. Journal of Biological Chemistry. 280(7). 6085–6093. 50 indexed citations
20.
Beckmann, Jan, et al.. (2004). PROLONGATION OF ALLOGRAFT SURVIVAL IN CCR7-DEFICIENT MICE. Transplantation. 77(12). 1809–1814. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026